Flushing
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Role of Prostaglandins on Niacin-Induced Flushing (NCT00930839) | Eastern Virginia Medical School | 2009-03-01 |
| Effects of Psyllium on Niacin Tolerability (NCT03370848) | VA Greater Los Angeles Healthcare System | 2009-03-01 |
| Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) (NCT00913081) | University of Pennsylvania | 2009-02-01 |
| Alternative Options to Minimize Niacin-Induced Flushing (NCT00895193) | Patrick Moriarty, MD, FACP, FACC | 2009-01-01 |
| Effect of MK0524A on Flushing Caused by Niacin (0524A-056) (NCT00533611) | Merck Sharp & Dohme LLC | 2007-04-01 |
| MK0524A Phase IIb Study (0524A-011)(COMPLETED) (NCT00536237) | Merck Sharp & Dohme LLC | 2004-08-01 |
| Endpoint Validation Study (0524A-015) (NCT00533676) | Merck Sharp & Dohme LLC | 2004-08-01 |
Track Flushing automatically
Every clearance here is in the API, with alerts when new ones post.